Switch to:
Isis Pharmaceuticals (NAS:ISIS)
Other Long-Term Assets
$4.5 Mil (As of Sep. 2014)

Isis Pharmaceuticals's other long-term assets for the quarter that ended in Sep. 2014 was $4.5 Mil.

Isis Pharmaceuticals's quarterly other long-term assets declined from Mar. 2014 ($9.5 Mil) to Jun. 2014 ($5.3 Mil) and declined from Jun. 2014 ($5.3 Mil) to Sep. 2014 ($4.5 Mil).

Isis Pharmaceuticals's annual other long-term assets increased from Dec. 2011 ($11.9 Mil) to Dec. 2012 ($12.5 Mil) but then declined from Dec. 2012 ($12.5 Mil) to Dec. 2013 ($9.9 Mil).


Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.

A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Isis Pharmaceuticals Annual Data

Other Long-Term Assets

Isis Pharmaceuticals Quarterly Data

Other Long-Term Assets 10.313.312.55.811.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial